Top Medical News

CMS Finalizes National Coverage Determination for Aducanumab, Amyloid-Targeting Antibodies for Alzheimer Disease

April 08, 2022

By Matt Hoffman

The NCD will allow for Medicare coverage of the therapy only in NIH- and FDA-approved studies and trials, noting that it will reevaluate the decision upon drug label changes from the FDA or when therapies are approved via “traditional approval” pathways.

NeurologyLive® Friday 5 — April 8, 2022

April 08, 2022

By NeurologyLive® Staff

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 1, 2022.

Multiple-Source Constant-Current DBS Shows Safety, Efficacy at Long-Term Follow-Up

April 08, 2022

By Marco Meglio

As a result of treatment with the Vercise Genus DBS system, patients reduced their use of anti-parkinsonian medications while maintaining improvements in quality of life.

Ubrogepant Demonstrates Several Positive Real-World Migraine Impacts in Patients With Prior Treatment Failure

April 07, 2022

By Marco Meglio

Following the switch to ubrogepant, more than half of patients with migraine had reduced use of triptans and more than one-third of patients had reduced use of anti-inflammatory drugs.

Understanding the Relationship Between Cerebral Arterial Blood Flow and Serum Neurofilament Light in MS

April 07, 2022

By Marco Meglio

Dejan Jakimovski, MD, PhD, research assistant professor, Buffalo Neuroimaging Analysis Center, discussed his presentation at AAN 2022 on the associations between cerebral hypoperfusion and increased axonal pathology in MS.

Featured

Mind Moments podcast

Episode 60: Improving Care and Raising Awareness for NMOSD

Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Friedmann Paul, MD.

NeuroVoices

NeuroVoices: Jiwoh Oh, MD, PhD, on Radiologically Isolated Syndrome as a Precursor to MS

The staff neurologist and medical director of the Barlo Multiple Sclerosis Program at St Michaels Hospital provided insight on the use of biomarkers to improve management of RIS and uncover more as it relates to MS.

AAN 2022

Coverage of the American Academy of Neurology Annual Meeting

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor.

Brain Games

Brain Games

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics.

MDA 2022

Coverage of the MDA Clinical and Scientific Conference 2022

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor.

EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD

EEGTalk

EEGTalk is a series dedicated to teaching EEG reading skills in neurology in a way that is both digestible and fun, hosted by Fábio A. Nascimento, MD, and Brandon Westover MD, PhD.

Latest Videos

MS COVID-19/Vaccine Advice
Novel Oral Treatment Selection in RRMS
No Evidence of Disease Activity in MS With Ozanimod
Once-Nightly Sodium Oxybate Preferred in Narcolepsy, ABBV-951 Shines in PD, Ocrelizumab Demonstrates Improved Cognitive Function in Progressive MS
Long-Term Advantages of Fenfluramine for Lennox-Gastaut Syndrome: Kelly Knupp, MD
The Therapeutic Advances in Efficacy for NMOSD: Bruce Cree, MD, PhD, MAS, FAAN
Comparing Neurological Examinations of COVID-19 With Other Viral Infections: Matthew Schindler, MD, PhD
SB623’s Potential for Traumatic Brain Injury: Peter J. McAllister, MD, FAAN
Ofatumumab Safety Data and Novel Approaches to MS
The Quick Neurologic Examination Tool in the PICU: Apirada Thongsing, MD
Understanding Long-Term Neurological Trajectories in Severe COVID-19 Cases: Jennifer Frontera, MD
Inebilizumab’s Efficacy in Patients With NMOSD Early in Disease Course: Bruce Cree, MD, PhD, MAS, FAAN
The DeepGRAI Registry in Multiple Sclerosis

Most Recent